4/14/2014 8:04:06 AM
The Scripps Research Institute (TSRI) has joined with Johnson & Johnson (J&J) Innovation Center and other partners to launch a new drug discovery effort designed to translate early-stage biomedical research projects into new treatments. The center is the early-stage R&D collaboration arm of Johnson & Johnson, the first of several biopharmas expected to join the initiative, called Scripps Advance. The biopharmas will be joined primarily by academic labs and other research institutions seeking to develop and commercialize promising technologies, both from TSRI and external partners.
Help employers find you! Check out all the jobs and post your resume.
comments powered by